Practical Guide to Hereditary Breast and Ovarian Cancer IV: Annual Meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2024
暫譯: 遺傳性乳腺癌與卵巢癌實用指南 IV：2024年日本遺傳性乳腺癌與卵巢癌組織年會

Arai, Masami, Ohno, Shinji, Sekine, Masayuki

Practical Guide to Hereditary Breast and Ovarian Cancer IV: Annual Meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2024
  • 出版商: Springer
  • 出版日期: 2026-04-02
  • 售價: $5,240
  • 貴賓價: 9.5 折 $4,978
  • 語言: 英文
  • 頁數: 227
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 9819565790
  • ISBN-13: 9789819565795
  • 相關分類: GAN 生成對抗網絡

    • 海外代購書籍(需單獨結帳)

商品描述

This book provides updated findings and trends of hereditary breast and ovarian cancer (HBOC) research and clinical practice, offering a comprehensive overview of the latest advancement. It captures the dynamic changes in HBOC treatment, driven by innovations such as poly (ADP-ribose) polymerase inhibitors and BRCA1/2 genetic testing. Key concepts explored include the DNA damage response, precision cancer medicine, and the challenges of regional cooperation in clinical practice. The book also addresses critical issues like homologous recombination deficiency (HRD) testing and the ethical considerations of preimplantation genetic testing. Contributions from leading experts provide insights into the latest evidence and trends, making this book an essential resource for understanding the evolving landscape of HBOC management.

Practical Guide to Hereditary Breast and Ovarian Cancer IV - Annual Meeting of the JOHBOC is written by the authors of the best-chosen works presented at the 4th Annual Meeting in 2024. Designed for breast surgeons, gynecologists, geneticists, and medical staff involved in HBOC practice, this book is also valuable for HBOC patients and their families. With its focus on the latest research and clinical applications, this volume is an indispensable guide for anyone seeking to stay informed about the current state and future directions of HBOC treatment in Japan and the world.

商品描述(中文翻譯)

本書提供了有關遺傳性乳腺癌和卵巢癌（HBOC）研究及臨床實踐的最新發現和趨勢，全面概述了最新的進展。它捕捉了HBOC治療中的動態變化，這些變化受到如聚（ADP-核糖）聚合酶抑制劑和BRCA1/2基因檢測等創新技術的推動。探討的關鍵概念包括DNA損傷反應、精準癌症醫學以及臨床實踐中區域合作的挑戰。本書還涉及了同源重組缺陷（HRD）檢測和植入前基因檢測的倫理考量等重要議題。來自領先專家的貢獻提供了對最新證據和趨勢的見解，使本書成為理解HBOC管理不斷演變的必備資源。

《遺傳性乳腺癌和卵巢癌實用指南 IV - JOHBOC年會》由2024年第4屆年會上最佳選擇作品的作者撰寫。該書專為乳腺外科醫生、婦產科醫生、遺傳學家及參與HBOC實踐的醫療人員設計，對HBOC患者及其家庭也具有重要價值。該卷專注於最新的研究和臨床應用，是任何希望了解日本及全球HBOC治療現狀和未來方向的人的不可或缺的指南。

作者簡介

Masami Arai
Masami Arai, MD, graduated from the Department of Medicine at Kagoshima University in 1986. He specializes in clinical genetic medicine for hereditary cancers, such as HBOC, and has worked at the Cancer Institute Hospital (January 2000-March 2018) and Juntendo University (April 2018-present). From 2014 to 2016, he led the Health Labour Sciences Research Grant Research Group on HBOC. During this period, he published the Guidebook for Diagnosis and Treatment of HBOC 2017, which established Japan's first clinical management guidelines for HBOC. At the same time, he contributed to the development of a nationwide registration system for BRCA1/2 mutation carriers. Currently, he serves as Professor in the Department of Clinical Genetics at Juntendo University and also oversees the institution's genetic counseling course.

Shinji Ohno
Dr Ohno is the Chairman of Japanese Organization of Hereditary Breast and Ovarian Cancer (JOHBOC). After postgraduate training at Kyushu University since 1984, he spent three years as a research fellow in the Department of Surgery II at Kyushu University since 1986 and another two years in Internal Medicine at the University of Texas Medical School, U.S.A. since 1989. Then assumed a position as Assistant Professor of the Department of Surgery II at Kyushu University between 1993 and 2000. Was the Director of the Department of Breast Oncology at the National Kyushu Cancer Center from 2000 to 2015. Since then, he has been Center Chief of Breast Oncology, and Deputy director of Cancer Institute Hospital in Tokyo. Since 1st September 2023, he has been the director of Sagara Hospital. Internationally, is a faculty of Advanced Breast Cancer International Consensus Conference, a member of the Guideline Committee of European Society for Medical Oncology, and an International Advisory Member of The Breast, and a Faculty of American College of Surgeon.

Masayuki Sekine
Department of Obstetrics and Gynecology
Graduate School of Medical Science, University of the Ryukyu
Education:
2002; Ph.D. Niigata University Graduate School of Medical and Dental Sciences
1994; Graduated, Faculty of Medicine, Niigata University
Professional Experience:
2023 - Present; Professor and Chairman, Department of Obstetrics and Gynecology, Graduate School of Medical Science, University of the Ryukyus
2015 - 2023; Associate Professor, Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences
2013 - 2015; Assistant Professor, Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences
2010 - 2013; Chief Gynecologist, Nagaoka Red Cross Hospital
2006 - 2010; Assistant Professor, Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences
2005 - 2006; Visiting Fellow, Harvard Institute of Medicine
2002 - 2005; Assistant Professor, Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences
1998 - 2002; Graduate Student, Niigata University Graduate School of Medical and Dental Sciences
1997 - 1998; Resident, Niigata City General Hospital
1996 - 1997; Resident, Akita Red Cross Hospital
1995 - 1996; Resident, Saiseikai Kawaguchi General Hospital
1994 - 1995; Resident, Department of Obstetrics and Gynecology, Niigata University Medical and Dental Hospital.

作者簡介(中文翻譯)

**新井正美**
新井正美醫師於1986年畢業於鹿兒島大學醫學系。他專注於遺傳性癌症的臨床遺傳醫學，如遺傳性乳腺卵巢癌（HBOC），曾在癌症研究所醫院工作（2000年1月-2018年3月）及順天堂大學（2018年4月至今）。在2014年至2016年間，他領導了HBOC的健康勞動科學研究補助研究小組。在此期間，他出版了《HBOC診斷與治療指南2017》，該指南建立了日本首個HBOC的臨床管理指導方針。同時，他也為全國性BRCA1/2突變攜帶者的登記系統的發展做出了貢獻。目前，他擔任順天堂大學臨床遺傳學系教授，並負責該機構的遺傳諮詢課程。

**大野信治**
大野醫師是日本遺傳性乳腺和卵巢癌組織（JOHBOC）的主席。自1984年以來，他在九州大學接受研究生培訓，並於1986年至1989年在九州大學外科第二學系擔任研究員三年，隨後在美國德克薩斯大學醫學院的內科部門工作兩年。1993年至2000年，他擔任九州大學外科第二學系的助理教授。2000年至2015年，他是國立九州癌症中心乳腺腫瘤科的主任。此後，他成為乳腺腫瘤科的中心主任，並擔任東京癌症研究所醫院的副院長。自2023年9月1日起，他成為佐賀醫院的院長。在國際上，他是進階乳腺癌國際共識會議的教員，歐洲醫學腫瘤學會指導方針委員會的成員，以及《The Breast》的國際顧問成員，並且是美國外科醫師學會的教員。

**關雅之**
婦產科
琉球大學醫學科學研究所
**教育背景：**
2002年；博士，新潟大學醫學與牙科科學研究所
1994年；畢業於新潟大學醫學部
**專業經歷：**
2023年至今；琉球大學醫學科學研究所婦產科教授及主任
2015年至2023年；新潟大學醫學與牙科科學研究所婦產科副教授
2013年至2015年；新潟大學醫學與牙科科學研究所婦產科助理教授
2010年至2013年；長岡紅十字醫院主治婦科醫師
2006年至2010年；新潟大學醫學與牙科科學研究所婦產科助理教授
2005年至2006年；哈佛醫學院訪問研究員
2002年至2005年；新潟大學醫學與牙科科學研究所婦產科助理教授
1998年至2002年；新潟大學醫學與牙科科學研究所研究生
1997年至1998年；新潟市綜合醫院住院醫師
1996年至1997年；秋田紅十字醫院住院醫師
1995年至1996年；埼玉會川口綜合醫院住院醫師
1994年至1995年；新潟大學醫學與牙科醫院婦產科住院醫師。

類似商品